Bausch Health Announces Participation In Upcoming Investor Conferences

Go back to Bausch Health Announces Participation In Upcoming Investor Conferences

RBC Capital Upgrades Bausch Health (BHC) to Outperform; 'Will Likely Be a Very Different Co. a Year from Now'

February 17, 2021 5:13 AM EST

(Updated - February 17, 2021 6:59 AM EST)

RBC Capital analyst Doug Miehm upgraded Bausch Health Companies (NYSE: BHC) from Sector Perform to Outperform with a price target of $42.00 (from $26.00), saying it will likely be a very different company ~12 months from now/.

The analyst comments... More